Cantabio Pharmaceuticals, Inc. (OTCPK:CTBO) announced that it has entered into a securities purchase agreement for a private placement of secured convertible debentures with existing investor, YA II PN, LTD., a fund managed by Yorkville Advisors Global LP for gross proceeds of $300,000 on November 20, 2017. The debenture carries a coupon of 5% per annum, a maturity date of one year after issuance. In addition, we must pay to the holder a fee equal to 7% of the amount of the debentures to assist in their monitoring costs for the debentures. The debenture may be converted into shares of our common stock at any time on or prior to maturity at the lower of $0.10 or 93% of the average of the three lowest daily VWAPs during the 10 consecutive trading days immediately preceding the conversion date, provided that as long as we are not in default under the debenture, the conversion price may never be less than $0.01. The company will issue securities pursuant to exemption under Regulation D. On the same date, the company announced that it has received $150,000 in its first tranche. The company will close a second tranche of $150,000 for within five days of the date of filing registration statement.